CDC Vaccine Advisory Panel to Meet on Severe Condition Linked to J&J’s COVID-19 Vaccine

Syringes with doses of the Johnson & Johnson COVID-19 vaccine are seen in California in a file photograph. Patrick T. Fallon/AFP via Getty Images

A panel of experts who advise the Centers for Disease Control and Prevention (CDC) on vaccines is meeting Thursday to discuss updates to a severe condition linked to Johnson & Johnson’s COVID-19 vaccine.

The panel will listen to presentations by CDC officials on thrombosis with thrombocytopenia syndrome (TTS), which U.S. drug regulators say has a “causal relationship” with the jab, according to a draft agenda for the meeting.